Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bindia Jharap

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Clinical and Translational Gastroenterology|March 4, 2016
Anal Neoplasia in Inflammatory Bowel Disease Is Associated With HPV and Perianal DiseaseJoannie Ruel, Huaibin Mabel Ko, Giulia Roda, et al.
Clinical Chemistry|December 28, 2007
Stability of thiopurine metabolites: a potential analytical biasPeer de Graaf, Nanne K H de Boer, Bindia Jharap, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 1, 2022
Immunomodulator Withdrawal From Anti-TNF Therapy Is Not Associated With Loss of Response in Inflammatory Bowel DiseaseRemi Mahmoud, Hans-Paul Schultheiss, Jonas Louwers, et al.
BMC Gastroenterology|May 7, 2011
Safety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitisMiloslav Kverka, Pavel Rossmann, Helena Tlaskalova-Hogenova, et al.
Alimentary Pharmacology & Therapeutics|September 24, 2021
Loss of response to anti-TNFα agents depends on treatment duration in patients with inflammatory bowel diseaseJohannes P D Schultheiss, Remi Mahmoud, Jonas M Louwers, et al.
The American Journal of Gastroenterology|September 4, 2007
Dose-dependent influence of 5-aminosalicylates on thiopurine metabolismNanne K H de Boer, Dennis R Wong, Bindia Jharap, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 27, 2010
Prolonged thioguanine therapy is well tolerated and safe in the treatment of ulcerative colitisDirk P van Asseldonk, Bindia Jharap, Dirk J Kuik, et al.
Gut|February 21, 2013
Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel diseaseBindia Jharap, Nanne K H de Boer, Pieter Stokkers, et al.
Journal of Crohn'S & Colitis|January 3, 2018
Thiopurines in Inflammatory Bowel Disease: New Findings and PerspectivesNanne K H de Boer, Laurent Peyrin-Biroulet, Bindia Jharap, et al.
Scandinavian Journal of Gastroenterology|June 18, 2019
Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patientsDirk P van Asseldonk, Melek Simsek, Nanne K H de Boer, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Clinical and Translational Gastroenterology|March 4, 2016
Anal Neoplasia in Inflammatory Bowel Disease Is Associated With HPV and Perianal DiseaseJoannie Ruel, Huaibin Mabel Ko, Giulia Roda, et al.
Clinical Chemistry|December 28, 2007
Stability of thiopurine metabolites: a potential analytical biasPeer de Graaf, Nanne K H de Boer, Bindia Jharap, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 1, 2022
Immunomodulator Withdrawal From Anti-TNF Therapy Is Not Associated With Loss of Response in Inflammatory Bowel DiseaseRemi Mahmoud, Hans-Paul Schultheiss, Jonas Louwers, et al.
BMC Gastroenterology|May 7, 2011
Safety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitisMiloslav Kverka, Pavel Rossmann, Helena Tlaskalova-Hogenova, et al.
Alimentary Pharmacology & Therapeutics|September 24, 2021
Loss of response to anti-TNFα agents depends on treatment duration in patients with inflammatory bowel diseaseJohannes P D Schultheiss, Remi Mahmoud, Jonas M Louwers, et al.
The American Journal of Gastroenterology|September 4, 2007
Dose-dependent influence of 5-aminosalicylates on thiopurine metabolismNanne K H de Boer, Dennis R Wong, Bindia Jharap, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 27, 2010
Prolonged thioguanine therapy is well tolerated and safe in the treatment of ulcerative colitisDirk P van Asseldonk, Bindia Jharap, Dirk J Kuik, et al.
Gut|February 21, 2013
Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel diseaseBindia Jharap, Nanne K H de Boer, Pieter Stokkers, et al.
Journal of Crohn'S & Colitis|January 3, 2018
Thiopurines in Inflammatory Bowel Disease: New Findings and PerspectivesNanne K H de Boer, Laurent Peyrin-Biroulet, Bindia Jharap, et al.
Scandinavian Journal of Gastroenterology|June 18, 2019
Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patientsDirk P van Asseldonk, Melek Simsek, Nanne K H de Boer, et al.
Pageof 4